Pharmacy Innovations Conference on Antithrombotic Therapy (PICAT)

Course Objectives

• describe, analyze, and critique recent antithrombotic clinical trial results and studies and project their impact on patient care.
• describe thrombotic risks associated with various types of heart valve replacements and how to modify approaches to antithrombotic management.
• evaluate the risk of gastrointestinal bleeding, describe pharmacological gastrointestinal-protection strategies, and make recommendations for appropriate antithrombotic therapy in patients with gastrointestinal resection/intervention surgery, active gastrointestinal bleeding or recent gastrointestinal bleeding.
• describe the new classification for recognizing atrial fibrillation and the supporting evidence for the utility of various devices that are available for detecting AF.
• describe updated treatment guidelines and recommendations for subclinical atrial fibrillation.
• assess a bleeding incidence with concurrent anticoagulation therapy and be aware of steps to implement a short- and long-term reversal management strategy. Considerations for decision support and management pathways will be presented.
• describe, analyze, and critique the use of artificial intelligence application to the management of antithrombotic therapy and the impact on patient care.

Course Outline

Instructors

Jean Connors, MD, Medical Director, Hemostatic Antithrombotic Stewardship and Medical Director, Anticoagulation Management Services, Hematology Division, Department of Medicine, Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Associate Professor of Medicine, Harvard Medical School, Boston, MA

William E. Dager, PharmD, BCPS, MCCM, FACCP, FASHP, FCSHP, Board of Directors, Anticoagulation Forum, Sacramento, CA

John Fanikos, BS, MBA, Strategic Initiatives, Thrombosis Forum of North America, Boston, MA

Scott Kaatz, DO, MSc, FACP, SFHM, Clinical Professor of Medicine - Wayne State University, Senior Staff Hospitalist, Medical Director for Professional Development and Research, Division of Hospital Medicine, Henry Ford Hospital, Detroit, MI

Sukit Ringwala, MD, EP, Cardiologist, University of Illinois, Chicago, Assistant Professor Loyola University Chicago, Stritch School of Medicine, Chicago, IL

Jessica J. Tilton, PharmD, Clinical Assistant Professor, College of Pharmacy, Medication Therapy Management Clinic, Clinical Coordinator, University of Illinois Chicago, College of Pharmacy, Pharmacy Practice, Chicago, IL

Toby C. Trujillo, PharmD, FCCP, FAHA, BCPS-AQ, Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical SciencesClinical Specialist - Anticoagulation/Cardiology, University of Colorado Hospital, Co-chair, Anticoagulation Subcommittee and Stewardship Program UC Health, Aurora, CO

Ellen Uppuluri, PharmD, BCACP, CACP, Clinical Assistant Professor Department of Pharmacy Practice, University of Illinois, Chicago College of Pharmacy Clinical Pharmacist, Antithrombosis Clinic University of Illinois, Chicago, IL

Adrian Wong, PharmD, MPH, FCCM, FCCP, BCCCP, Clinical Pharmacy Specialist, Medical ICU, Beth Israel Deaconess Medical Center, Boston, MA

Planning Committee

Andrea Porter, PharmD, University of Wisconsin, Madison, WI, Conference Chair
John Fanikos, RPh, MBA, Brigham and Women’s Hospital, Boston, MA, Program Chair
Nathan P. Clark, PharmD, FCCP, BCPS, Kaiser Permanente Colorado, Aurora, CO
William E. Dager, PharmD, UC Davis Medical Center, Sacramento, CA
Michael P. Gulseth, PharmD, Sanford USD Medical Center, Sioux Falls, SD
Candice Garwood, PharmD, FCCP, BCPS, BCACP, Wayne State University, Detroit, MI
Kenneth A. Kellick, PharmD, VA Western NY Healthcare System, Buffalo, NY
Anne Rose, PharmD, University of Wisconsin Hospitals and Clinics, Madison, WI
Maureen A. Smythe, PharmD, FCCP, William Beaumont Hospital, Royal Oak, MI
Sarah A. Spinler, PharmD, Binghamton University School of Pharmacy and Pharmaceutical Studies, Binghamton, NY
Nancy L. Shapiro, PharmD, FCCP, BCACP, CACP, Antithrombosis Clinic, UI Health
Lynda Thomson, PharmD, Thomas Jefferson University, Philadelphia, PA

CE Credit

Credit Designation Statement

Accreditation Council for Pharmacy Education (ACPE)

The University of Wisconsin–Madison ICEP designates this enduring knowledge based activity for 5.75 hours or 0.575 CEUs of CPE credit. Credit can be earned by successfully attending the activity and completing the evaluation. There will be no partial credit awarded for partial completion.

Live CEU's: ACPE# JA0000358-0000-24-064-L01-P (5.75 hours/0.575 CEU's)
Documentation of attendance (log-in to Zoom and time tracking) of the live virtual conference is mandatory to receive CE.

Continuing Education Units (CEUs)

The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.575 CEUs or 5.75 hours.